While extremely interesting, these observations were not confirmed in mammalian cells until the Stegmaier’s laboratory embarked on a large gene expression-based screening (GE-HTS) effort to identify inhibitors of oncogenic NOTCH1 signatures or enhancer of NOTCH1 HD mutant L1601P∆P activity in T-ALL. Here, NOTCH1 is linked to acute lymphoblastic leukemia.